Placebo in history

Last updated

The word placebo was used in a medicinal context in the late 18th century to describe a "commonplace method or medicine" and in 1811 it was defined as "any medicine adapted more to please than to benefit the patient". Although this definition contained a derogatory implication, [1] it did not necessarily imply that the remedy had no effect. [2]

Contents

Placebos have featured in medical use until well into the twentieth century. [3] In 1955 Henry K. Beecher published an influential paper entitled The Powerful Placebo which proposed idea that placebo effects were clinically important. [4] Subsequent re-analysis of his materials, however, found in them no evidence of any "placebo effect". [5]

Etymology

Placebo is the opening word of the antiphon of vespers in the Office of the Dead, used as a name for the service as a whole. The full sentence, from the Vulgate, is Placebo Domino in regione vivorum 'I will please the Lord in the land of the living', from Psalm 116:9. [6] [7] To sing placebo at a funeral came to mean to falsely claim a connection to the deceased to get a share of the funeral meal, and hence a flatterer, and so a deceptive act to please. [1]

Early medical usage

Doctors and surgeons such as Ambroise Pare traditionally emphasized the importance of consoling the patient through the use of 'placebos'. This is the title page to one of Pare's works. Title page of Ambroise Pare's Ouevres.jpg
Doctors and surgeons such as Ambroise Paré traditionally emphasized the importance of consoling the patient through the use of 'placebos'. This is the title page to one of Paré's works.

In the practice of medicine it had been long understood that, as Ambroise Paré (1510–1590) had expressed it, the physician's duty was to "cure occasionally, relieve often, console always" ("Guérir quelquefois, soulager souvent, consoler toujours"). Accordingly, placebos were widespread in medicine until the 20th century, and were often endorsed as necessary deceptions. [3]

According to Nicholas Jewson, eighteenth century English medicine was gradually moving away from a model in which the patient had considerable interaction with the physician – and, through this consultative relationship, had an equal influence on the physician's therapeutic approach. It was moving towards a paradigm in which the patient became the recipient of a more standardized form of intervention that was determined by the prevailing opinions of the medical profession of the day. [8]

Jewson characterized this as parallel to the changes that were taking place in the manner in which medical knowledge was being produced; namely, a transition from "bedside medicine", through to "hospital medicine", and finally to "laboratory medicine". [9]

The last vestiges of the "consoling" approach to treatment were the prescription of morale-boosting and pleasing remedies, such as the "sugar pill", electuary or pharmaceutical syrup; all of which had no known pharmacodynamic action, even at the time. Those doctors who provided their patients with these sorts of morale-boosting therapies (which, while having no pharmacologically active ingredients, provided reassurance and comfort) did so either to reassure their patients while the Vis medicatrix naturae (i.e., "the healing power of nature") performed its normalizing task of restoring them to health, or to gratify their patients' need for an active treatment.[ citation needed ]

In 1811, Hooper's Quincy's Lexicon–Medicum defined placebo as "an epithet given to any medicine adapted more to please than benefit the patient".

Early implementations of placebo controls date back to 16th-century Europe with Catholic efforts to discredit exorcisms. Individuals who claimed to be possessed by demonic forces were given false holy objects. If the person reacted with violent contortions, it was concluded that the possession was purely imagination. [10]

Use of the placebo effect as a medical treatment has been controversial throughout history, and was common until the mid twentieth century. [3] In 1903 Richard Cabot concluded that it should be avoided because it is deceptive. Newman points out the "placebo paradox" – it may be unethical to use a placebo, but also unethical "not to use something that heals". He suggests to solve this dilemma by appropriating the meaning response in medicine, that is make use of the placebo effect, as long as the "one administering... is honest, open, and believes in its potential healing power". [11]

John Haygarth was the first to investigate the efficacy of the placebo effect in the 18th century. [12] He tested a popular medical treatment of his time, called "Perkins tractors", and concluded that the remedy was ineffectual by demonstrating that the results from a dummy remedy were just as useful as from the alleged "active" remedy. [13]

Émile Coué, a French pharmacist, working as an apothecary at Troyes between 1882 and 1910, also advocated the effectiveness of the "Placebo Effect". He became known for reassuring his clients by praising each remedy's efficiency and leaving a small positive notice with each given medication. His book Self-Mastery Through Conscious Autosuggestion was published in England (1920) and in the United States (1922).

Placebos remained widespread in medicine until the 20th century, and they were sometimes endorsed as necessary deceptions. [3] In 1903, Richard Cabot said that he was brought up to use placebos, [3] but he ultimately concluded by saying that "I have not yet found any case in which a lie does not do more harm than good". [11]

T. C. Graves first defined the "placebo effect" in a published paper in The Lancet in 1920.[ original research? ] [14] He spoke of "the placebo effects of drugs" being manifested in those cases where "a real psychotherapeutic effect appears to have been produced". [15]

Placebo effect

Metallic Tractors. Caricature of a quack treating a patient with Perkins Patent Tractors by James Gillray, 1801. James Gillray, "Metallic Tractors", showing Elisha Perkins Wellcome M0010466.jpg
Metallic Tractors. Caricature of a quack treating a patient with Perkins Patent Tractors by James Gillray, 1801.

The placebo effect of new drugs was known anecdotally in the 18th century, as demonstrated by Michel-Philippe Bouvart's 1780s quip to a patient that she should "take [a remedy] ... and hurry up while it [still] cures." [16] A similar sentiment was expressed by William Heberden in 1803 [17] and Armand Trousseau in 1833. [18] It is often attributed to William Osler (1901) but without a precise source, and it does not appear in his publications. [19] [20]

The first to recognize and demonstrate the placebo effect was English physician John Haygarth in 1799. [21] He tested a popular medical treatment of his time, called "Perkins tractors", which were metal pointers supposedly able to 'draw out' disease. They were sold at the extremely high price of five guineas, and Haygarth set out to show that the high cost was unnecessary. He did this by comparing the results from dummy wooden tractors with a set of allegedly "active" metal tractors, and published his findings in a book On the Imagination as a Cause & as a Cure of Disorders of the Body. [22]

The wooden pointers were just as useful as the expensive metal ones, showing "to a degree which has never been suspected, what powerful influence upon diseases is produced by mere imagination". [23] While the word placebo had been used since 1772, this is the first real demonstration of the placebo effect.[ citation needed ]

John Haygarth was the first to demonstrate the placebo effect in 1799. John Haygarth.jpg
John Haygarth was the first to demonstrate the placebo effect in 1799.

In modern times the first to define and discuss the "placebo effect" was T.C. Graves, in a 1920 paper in The Lancet . [24] He spoke of "the placebo effects of drugs" being manifested in those cases where "a real psychotherapeutic effect appears to have been produced". [25]

At the Royal London Hospital in 1933, William Evans and Clifford Hoyle experimented with 90 subjects and published studies which compared the outcomes from the administration of an active drug and a dummy simulator ("placebo") in the same trial. The experiment displayed no significant difference between drug treatment and placebo treatment, leading the researchers to conclude that the drug exerted no specific effects in relation to the conditions being treated. [26] A similar experiment was carried out by Harry Gold, Nathaniel Kwit and Harold Otto in 1937, with the use of 700 subjects. [27]

In 1946, the Yale biostatistician and physiologist E. Morton Jellinek described the "placebo reaction" or "response". He probably used the terms "placebo response" and "placebo reaction" as interchangeable. [28] Henry K. Beecher's 1955 paper The Powerful Placebo was the first to use the term "placebo effect", which he contrasts with drug effects. [29] Beecher suggested placebo effects occurred in about 35% of people. However, this paper has been criticized for failing to distinguish the placebo effect from other factors, and for thereby encouraging an inflated notion of the placebo effect, [30] and a 1997 re-analysis failed to support Beecher's conclusions. [5]

In 1955, Henry K. Beecher published a paper entitled The Powerful Placebo. Since that time, 40 years ago, the placebo effect has been considered a scientific fact. Beecher was the first scientist to quantify the placebo effect. [...] This publication is still the most frequently cited placebo reference. Recently Beecher’s article was reanalyzed with surprising results: In contrast to his claim, no evidence was found of any placebo effect in any of the studies cited by him.

— Kienle & Kiene, The Powerful Placebo Effect: Fact or Fiction? [5]

In 1961 Henry K. Beecher concluded [31] that surgeons he categorized as enthusiasts relieved their patients' chest pain and heart problems more than skeptic surgeons. [11]

In 1961 Walter Kennedy introduced the word nocebo to refer to a neutral substance that creates harmful effects in a patient who takes it. [3] [32]

Beginning in the 1960s, the placebo effect became widely recognized and placebo-controlled trials became the norm in the approval of new medications. [33]

Dylan Evans argues that placebos are linked with activation of the acute-phase response so will work only on subjective conditions such as pain, swelling, stomach ulcers, depression, and anxiety that are linked to this. [34]

A 2001 systematic review of clinical trials concluded that there was no evidence of clinically important effects, except perhaps in the treatment of pain and continuous subjective outcomes. [4] The authors later published a Cochrane review with similar conclusions (updated as of 2010). [35] Most studies have attributed the difference from baseline until the end of the trial to a placebo effect, but the reviewers examined studies which had both placebo and untreated groups in order to distinguish the placebo effect from the natural progression of the disease. [4]

Placebo observations differ between individuals. [36] [37] In the 1950s, there was considerable research to find whether there was a specific personality to those that responded to placebos. The findings could not be replicated [38] and it is now thought to have no effect. [39]

The word obecalp, "placebo" spelled backwards, was coined by an Australian doctor in 1998 when he recognised the need for a freely available placebo. [40] The word is sometimes used to make the use or prescription of fake medicine less obvious to the patient. [41]

It has been suggested that a distinction exists between the placebo effect (which applies to a group) and the placebo response (which is individual). [42]

See also

Related Research Articles

Alternative medicine is any practice that aims to achieve the healing effects of medicine despite lacking biological plausibility, testability, repeatability or evidence of effectiveness. Unlike modern medicine, which employs the scientific method to test plausible therapies by way of responsible and ethical clinical trials, producing repeatable evidence of either effect or of no effect, alternative therapies reside outside of medical science and do not originate from using the scientific method, but instead rely on testimonials, anecdotes, religion, tradition, superstition, belief in supernatural "energies", pseudoscience, errors in reasoning, propaganda, fraud, or other unscientific sources. Frequently used terms for relevant practices are New Age medicine, pseudo-medicine, unorthodox medicine, holistic medicine, fringe medicine, and unconventional medicine, with little distinction from quackery.

<span class="mw-page-title-main">Homeopathy</span> Pseudoscientific system of alternative medicine

Homeopathy or homoeopathy is a pseudoscientific system of alternative medicine. It was conceived in 1796 by the German physician Samuel Hahnemann. Its practitioners, called homeopaths or homeopathic physicians, believe that a substance that causes symptoms of a disease in healthy people can cure similar symptoms in sick people; this doctrine is called similia similibus curentur, or "like cures like". Homeopathic preparations are termed remedies and are made using homeopathic dilution. In this process, the selected substance is repeatedly diluted until the final product is chemically indistinguishable from the diluent. Often not even a single molecule of the original substance can be expected to remain in the product. Between each dilution homeopaths may hit and/or shake the product, claiming this makes the diluent "remember" the original substance after its removal. Practitioners claim that such preparations, upon oral intake, can treat or cure disease.

<span class="mw-page-title-main">Placebo</span> Substance or treatment of no therapeutic value

A placebo can be roughly defined as a sham medical treatment. Common placebos include inert tablets, inert injections, sham surgery, and other procedures.

<span class="mw-page-title-main">Randomized controlled trial</span> Form of scientific experiment

A randomized controlled trial is a form of scientific experiment used to control factors not under direct experimental control. Examples of RCTs are clinical trials that compare the effects of drugs, surgical techniques, medical devices, diagnostic procedures, diets or other medical treatments.

<span class="mw-page-title-main">Statin</span> Class of drugs used to lower cholesterol levels

Statins are a class of medications that reduce illness and mortality in people who are at high risk of cardiovascular disease. They are the most commonly prescribed cholesterol-lowering drugs, and are also known as HMG-CoA reductase inhibitors.

In a blind or blinded experiment, information which may influence the participants of the experiment is withheld until after the experiment is complete. Good blinding can reduce or eliminate experimental biases that arise from a participants' expectations, observer's effect on the participants, observer bias, confirmation bias, and other sources. A blind can be imposed on any participant of an experiment, including subjects, researchers, technicians, data analysts, and evaluators. In some cases, while blinding would be useful, it is impossible or unethical. For example, it is not possible to blind a patient to their treatment in a physical therapy intervention. A good clinical protocol ensures that blinding is as effective as possible within ethical and practical constraints.

<span class="mw-page-title-main">Duloxetine</span> Antidepressant medication used also for treatment of anxiety and chronic pain

Duloxetine, sold under the brand name Cymbalta among others, is a medication used to treat major depressive disorder, generalized anxiety disorder, obsessive-compulsive disorder, fibromyalgia, neuropathic pain and central sensitization. It is taken by mouth.

<span class="mw-page-title-main">Atorvastatin</span> Cholesterol-lowering medication

Atorvastatin is a statin medication used to prevent cardiovascular disease in those at high risk and to treat abnormal lipid levels. For the prevention of cardiovascular disease, statins are a first-line treatment. It is taken by mouth.

A nocebo effect is said to occur when negative expectations of the patient regarding a treatment cause the treatment to have a more negative effect than it otherwise would have. For example, when a patient anticipates a side effect of a medication, they can experience that effect even if the "medication" is actually an inert substance. The complementary concept, the placebo effect, is said to occur when positive expectations improve an outcome. The nocebo effect is also said to occur in someone who falls ill owing to the erroneous belief that they were exposed to a toxin, e.g. a physical phenomenon they believe is harmful, such as EM radiation.

<span class="mw-page-title-main">Nabiximols</span> Specific cannabis extract

Nabiximols is a specific Cannabis extract that was approved in 2010 as a botanical drug in the United Kingdom. Nabiximols is sold as a mouth spray intended to alleviate neuropathic pain, spasticity, overactive bladder, and other symptoms of multiple sclerosis; it was developed by the UK company GW Pharmaceuticals. In 2019, it was proposed that following application of the spray, nabiximols is washed away from the oral mucosa by the saliva flow and ingested into the stomach, with subsequent absorption from the gastro-intestinal tract. Nabiximols is a combination drug standardized in composition, formulation, and dose. Its principal active components are the cannabinoids: tetrahydrocannabinol (THC) and cannabidiol (CBD). Each spray delivers a dose of 2.7 mg THC and 2.5 mg CBD.

<span class="mw-page-title-main">Agomelatine</span> Atypical antidepressant classified primarily as a melatonin receptor agonist

Agomelatine, sold under the brand names Valdoxan and Thymanax, among others, is an atypical antidepressant most commonly used to treat major depressive disorder and generalized anxiety disorder. One review found that it is as effective as other antidepressants with similar discontinuation rates overall but fewer discontinuations due to side effects. Another review also found it was similarly effective to many other antidepressants.

<span class="mw-page-title-main">Henry K. Beecher</span> American medical academic

Henry Knowles Beecher was a pioneering American anesthesiologist, medical ethicist, and investigator of the placebo effect at Harvard Medical School.

<span class="mw-page-title-main">Perindopril</span> High blood pressure medication

Perindopril is a medication used to treat high blood pressure, heart failure, or stable coronary artery disease.

<span class="mw-page-title-main">Ted Kaptchuk</span> American medical academic

Ted Jack Kaptchuk is an American medical researcher who holds professorships in medicine and in global health and social medicine at Harvard Medical School. He researches the placebo effect within the field of placebo studies.

Peter Christian Gøtzsche is a Danish physician, medical researcher, and former leader of the Nordic Cochrane Center at Rigshospitalet in Copenhagen, Denmark. He is a co-founder of the Cochrane Collaboration and has written numerous reviews for the organization. His membership in Cochrane was terminated by its Governing Board of Trustees on 25 September 2018. During the COVID-19 pandemic, Gøtzsche was criticised for spreading disinformation about COVID-19 vaccines.

<span class="mw-page-title-main">Placebo-controlled study</span>

Placebo-controlled studies are a way of testing a medical therapy in which, in addition to a group of subjects that receives the treatment to be evaluated, a separate control group receives a sham "placebo" treatment which is specifically designed to have no real effect. Placebos are most commonly used in blinded trials, where subjects do not know whether they are receiving real or placebo treatment. Often, there is also a further "natural history" group that does not receive any treatment at all.

The philosophy of medicine is a branch of philosophy that explores issues in theory, research, and practice within the field of health sciences. More specifically in topics of epistemology, metaphysics, and medical ethics, which overlaps with bioethics. Philosophy and medicine, both beginning with the ancient Greeks, have had a long history of overlapping ideas. It was not until the nineteenth century that the professionalization of the philosophy of medicine came to be. In the late twentieth century, debates among philosophers and physicians ensued of whether the philosophy of medicine should be considered a field of its own from either philosophy or medicine. A consensus has since been reached that it is in fact a distinct discipline with its set of separate problems and questions. In recent years there have been a variety of university courses, journals, books, textbooks and conferences dedicated to the philosophy of medicine.

<span class="mw-page-title-main">EMA401</span> Chemical compound

EMA401 is a drug under development for the treatment of peripheral neuropathic pain. Trials were discontinued in 2015, with new trials scheduled to begin March, 2018. It was initially established as a potential drug option for patients suffering pain caused by postherpetic neuralgia. It may also be useful for treating various types of chronic neuropathic pain EMA401 has shown efficacy in preclinical models of shingles, diabetes, osteoarthritis, HIV and chemotherapy. EMA401 is a competitive antagonist of angiotensin II type 2 receptor (AT2R) being developed by the Australian biotechnology company Spinifex Pharmaceuticals. EMA401 target angiotensin II type 2 receptors, which may have importance for painful sensitisation.

<span class="mw-page-title-main">Jeremy Howick</span> Canadian-UK philosopher of science

Jeremy Howick is a Canadian-born, British residing clinical epidemiologist and philosopher of science. He researches evidence-based medicine, clinical empathy and the philosophy of medicine, including the use of placebos in clinical practice and clinical trials. He is the author of over 100 peer-reviewed papers, as well as two books, The Philosophy of Evidence-Based Medicine in 2011, and Doctor You in 2017. In 2016, he received the Dawkins & Strutt grant from the British Medical Association to study pain treatment. He publishes in Philosophy of Medicine and medical journals. He is a member of the Sigma Xi research honours society.

The infinitesimally low concentration of homeopathic preparations, which often lack even a single molecule of the diluted substance, has been the basis of questions about the effects of the preparations since the 19th century. Modern advocates of homeopathy have proposed a concept of "water memory", according to which water "remembers" the substances mixed in it, and transmits the effect of those substances when consumed. This concept is inconsistent with the current understanding of matter, and water memory has never been demonstrated to exist, in terms of any detectable effect, biological or otherwise.

References

  1. 1 2 Shapiro AK (1968). "Semantics of the placebo". Psychiatric Quarterly. 42 (4): 653–95. doi: 10.1007/BF01564309 . PMID   4891851. S2CID   2733947.
  2. ↑ Kaptchuk TJ (June 1998). "Powerful placebo: the dark side of the randomised controlled trial". The Lancet. 351 (9117): 1722–5. doi:10.1016/S0140-6736(97)10111-8. PMID   9734904. S2CID   34023318.
  3. 1 2 3 4 5 6 de Craen AJ, Kaptchuk TJ, Tijssen JG, Kleijnen J (October 1999). "Placebos and placebo effects in medicine: historical overview". Journal of the Royal Society of Medicine. 92 (10): 511–5. doi:10.1177/014107689909201005. PMC   1297390 . PMID   10692902.
  4. 1 2 3 Hróbjartsson A, Gøtzsche PC (May 2001). "Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment". The New England Journal of Medicine. 344 (21): 1594–602. doi: 10.1056/NEJM200105243442106 . PMID   11372012.
  5. 1 2 3 Kienle GS, Kiene H (December 1997). "The powerful placebo effect: fact or fiction?". Journal of Clinical Epidemiology. 50 (12): 1311–8. doi:10.1016/s0895-4356(97)00203-5. PMID   9449934.
  6. ↑ Psalms 116:9
  7. ↑ Jacobs B (April 2000). "Biblical origins of placebo". Journal of the Royal Society of Medicine. 93 (4): 213–4. doi:10.1177/014107680009300419. PMC   1297986 . PMID   10844895.
  8. ↑ Nicholas D. Jewson (September 1974). "Medical Knowledge and the Patronage System in 18th Century England". Sociology. 8 (3): 369–385. doi:10.1177/003803857400800302. S2CID   143768672.
  9. ↑ Nicholas D. Jewson (1976). "The Disappearance of the Sick-Man from Medical Cosmology, 1770–1870". Sociology. 10 (2): 227. doi:10.1177/003803857601000202. S2CID   144097257.
  10. ↑ Beauregard M (2012). Brain Wars: The Scientific Battle Over the Existence of the Mind and the Proof That Will Change the Way We Live Our Lives. New York: HarperCollins Publishers. p. 21. ISBN   978-0-06-207156-9.
  11. 1 2 3 Newman DH (2008). Hippocrates' Shadow. Scribner. pp. 134–59. ISBN   978-1-4165-5153-9.
  12. ↑ Booth C (August 2005). "The rod of Aesculapios: John Haygarth (1740-1827) and Perkins' metallic tractors". Journal of Medical Biography. 13 (3): 155–61. doi:10.1177/096777200501300310. PMID   16059528. S2CID   208293370.
  13. ↑ Haygarth J (1800). "Of the Imagination, as a Cause and as a Cure of Disorders of the Body; Exemplified by Fictitious Tractors, and Epidemical Convulsions". Bath: Crutwell. Archived from the original on December 15, 2013.
  14. ↑ Graves TC (1920). "Commentary on a case of Hystero-epilepsy with delayed puberty". The Lancet . 196 (5075): 1135. doi:10.1016/S0140-6736(01)00108-8 . Retrieved January 2, 2014.
  15. ↑ Yapko MD (2012). Trancework: An Introduction to the Practice of Clinical Hypnosis. Routledge. p. 123. ISBN   978-0-415-88494-5.
  16. ↑ Gaston de Lévis, Souvenirs et portraits, 1780-1789, 1813, p. 240
  17. ↑ William Heberden, Commentaries on the History and Cure of Diseases, London, 1802,p. 40
  18. ↑ Armand Trousseau, Dictionnaire de Médecine, 1833 (page unspecified), as quoted in H. Bernheim, Suggestive Therapeutics, 1889 (page unspecified), quoted in "Competitive Probems in the Drug Industry", U.S. Senate hearings, 1968, p. 3008.
  19. ↑ Charles Murphy, "Guest blog", Emergency Medical Journal, March 30, 2014
  20. ↑ Donald L. Blanchard, Daniel M. Albert, "Historical Excerpts and Quotations Corner", American Academy of Ophthalmology, May 9, 2018
  21. ↑ Booth, C. (2005). "The rod of Aesculapios: John Haygarth (1740-1827) and Perkins' metallic tractors". Journal of Medical Biography. 13 (3): 155–161. doi:10.1177/096777200501300310. PMID   16059528. S2CID   208293370.
  22. ↑ Haygarth, J., Of the Imagination, as a Cause and as a Cure of Disorders of the Body; Exemplified by Fictitious Tractors, and Epidemical Convulsions Archived December 15, 2013, at the Wayback Machine , Crutwell, (Bath), 1800.
  23. ↑ Wootton, David. Bad medicine: Doctors doing harm since Hippocrates. Oxford University Press, 2006.
  24. ↑ T. C. Graves (1920). "Commentary on a case of Hystero-epilepsy with delayed puberty". The Lancet . 196 (5075): 1135. doi:10.1016/s0140-6736(01)00108-8 . Retrieved January 2, 2014.
  25. ↑ Michael D. Yapko (2012). Trancework: An Introduction to the Practice of Clinical Hypnosis. Routledge. p. 123. ISBN   9780415884945.
  26. ↑ Evans W, Hoyle C (1933). "The comparative value of drugs used in the continuous treatment of angina pectoris". Quarterly Journal of Medicine. Archived from the original on January 2, 2014. Retrieved January 2, 2014.
  27. ↑ Gold H, Kwit NT, Otto H (1937). "The Xanthines (Theobromine and Aminophyllin) in the treatment of cardiac pain". JAMA: The Journal of the American Medical Association. 108 (26): 2173. doi:10.1001/jama.1937.02780260001001. Archived from the original on May 19, 2011. Retrieved January 2, 2014.
  28. ↑ Jellinek, E. M. "Clinical Tests on Comparative Effectiveness of Analgesic Drugs", Biometrics Bulletin, Vol.2, No.5, (October 1946), pp. 87–91.
  29. ↑ Henry K. Beecher (1955). "The Powerful Placebo". Journal of the American Medical Association. 159 (17): 1602–6. doi:10.1001/jama.1955.02960340022006. PMID   13271123. S2CID   3173505.
  30. ↑ Finniss DG, Kaptchuk TJ, Miller F, Benedetti F (February 2010). "Biological, clinical, and ethical advances of placebo effects". Lancet. 375 (9715): 686–95. doi:10.1016/S0140-6736(09)61706-2. PMC   2832199 . PMID   20171404.
  31. ↑ Beecher HK (July 1961). "Surgery as placebo. A quantitative study of bias". JAMA: The Journal of the American Medical Association. 176 (13): 1102–7. doi:10.1001/jama.1961.63040260007008. PMID   13688614.
  32. ↑ Kennedy, W. P., "The Nocebo Reaction", Medical World, Vol.95, (September 1961), pp. 203–5.
  33. ↑ Kaptchuk TJ (1998). "Intentional ignorance: a history of blind assessment and placebo controls in medicine". Bulletin of the History of Medicine. 72 (3): 389–433. doi:10.1353/bhm.1998.0159. PMID   9780448. S2CID   10931827.
  34. ↑ Evans D (2003). Placebo: the belief effect. London: HarperCollins. ISBN   978-0-00-712612-5.
  35. ↑ Hróbjartsson A, Gøtzsche PC (January 2010). Hróbjartsson A (ed.). "Placebo interventions for all clinical conditions". The Cochrane Database of Systematic Reviews. 106 (1): CD003974. doi:10.1002/14651858.CD003974.pub3. PMC   7156905 . PMID   20091554.
  36. ↑ Benedetti F (March 1996). "The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia". Pain. 64 (3): 535–43. doi:10.1016/0304-3959(95)00179-4. PMID   8783319. S2CID   37893726.
  37. ↑ Levine JD, Gordon NC, Bornstein JC, Fields HL (July 1979). "Role of pain in placebo analgesia". Proceedings of the National Academy of Sciences of the United States of America. 76 (7): 3528–31. Bibcode:1979PNAS...76.3528L. doi: 10.1073/pnas.76.7.3528 . PMC   383861 . PMID   291020.
  38. ↑ Doongaji DR, Vahia VN, Bharucha MP (April 1978). "On placebos, placebo responses and placebo responders. (A review of psychological, psychopharmacological and psychophysiological factors). I. Psychological factors". Journal of Postgraduate Medicine. 24 (2): 91–7. PMID   364041.
  39. ↑ Hoffman GA, Harrington A, Fields HL (2005). "Pain and the placebo: what we have learned". Perspectives in Biology and Medicine. 48 (2): 248–65. doi:10.1353/pbm.2005.0054. PMID   15834197. S2CID   1037796.
  40. ↑ Axtens, Michael (August 8, 1998). "Letters to editor: Mind Games". New Scientist.
  41. ↑ E.g. see Gulf War Veteran Gets Placebos Instead Of Real Medicine Archived February 4, 2009, at the Wayback Machine or BehindTheMedspeak: Obecalp.
  42. ↑ Hoffman GA, Harrington A, Fields HL (2005). "Pain and the placebo: what we have learned". Perspectives in Biology and Medicine. 48 (2): 248–65. doi:10.1353/pbm.2005.0054. PMID   15834197. S2CID   1037796.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.